LodeHQ
AI news for people who shipFree, by email

US Business · Thursday, 9 July 2026 · Issue 35 · 13 stories

Trump Iran claim sinks airlines, sends oil spiking

Markets & Indices

Europe’s stocks are cheap gems despite a stagnant economy

The Economist argues that while Europe’s economy struggles with low growth and high energy costs, its equity markets trade at significant discounts to fundamentals, offering contrarian investors a buying opportunity. The undervaluation stems from export‑oriented firms and cash‑rich balance sheets that could thrive once the slowdown eases.

economist.com ↗4 min read at source

Companies & Earnings

AstraZeneca’s heart‑drug flop erases $27 B market value

AstraZeneca’s experimental heart‑drug Wainua missed its primary endpoint in a Phase III trial for transthyretin‑mediated amyloid cardiomyopathy, sending the stock down nearly 9% in London and 8% in U.S. pre‑market trading. The miss wipes about $27 billion off the company's market value and raises questions about its ability to expand Wainua beyond its existing indications.

cnbc.com ↗2 min read at source

The Fed & Economy

Deals & Wall Street

Big Banks Eye Fiserv Debit Networks to Sidestep Fee Caps

JPMorgan, Bank of America, Wells Fargo and PNC have floated buying Fiserv's STAR or Accel debit networks. Owning the infrastructure would let them dodge the Durbin Amendment's cap on interchange fees, potentially boosting bank revenues and raising merchant costs. The talks are tentative but markets reacted positively, with bank shares up in pre‑market trade.

investing.com ↗7 min read at source

You’re caught up.

That was all 13 stories in the 9 July issue.